Products
Streptokinase was commercially available as an injectable in many countries (Streptase, off label). It is still available in other countries.
Structure and properties
Streptokinase is a protein derived from group C hemolytic streptococci.
Effects
Streptokinase (ATC B01AD01) has fibrinolytic and thrombolytic properties. It combines with plasminogen to form a streptokinase-plasminogen complex. This complex converts plasminogen to plasmin, which enables the degradation of fibrin and thus the blood clot.
Indications
- Myocardial infarction
- Deep vein thrombosis
- Pulmonary embolism
- Acute and subacute thrombosis
- Arterial occlusive diseases
Dosage
According to the SmPC. The drug is administered intravenously or locally intravascularly.
Contraindications
For complete precautions, see the drug label.
Adverse effects
The most common possible adverse effects include bleeding.